People with Merkel cell, gynecological, gastric and head and neck cancers may be eligible to participate in a clinical trial at Sanford Health testing the effectiveness of an investigational drug called “Nivolumab”…
That’s Dr. Chad Spanos. He is the clinical trials principal investigator at Sanford Health in Sioux Falls. He says Nivolumab is currently being used in combination with other therapies to treat melanoma and non-small cell lung cancer…
Spanos says drugs like Nivolumab are able to take the brakes off of the immune system….
For more information about eligibility, call 87-SURVIVAL
